Get the latest news and updates on FINTECH.TV

Innovating in Adversity: How OS Therapies is Pioneering New Cancer Treatments

In this segment, filmed at The Jones Healthcare and Technology Innovation Conference, Vince Molinari had the pleasure of welcoming back Paul Romnes, the chairman and CEO of OS Therapies. The pair discussed the company’s recent achievements, including their successful acquisition of assets related to their Listeria immunotherapy platform, which eliminates royalties and milestone payments, allowing for a more streamlined path to commercialization.

Advertisement

Latest articles

Related articles